Regulatory Excellence Accutest is a globally accredited CRO with a strong regulatory track record, having multiple USFDA, WHO, DCGI, and EMA inspections cleared. This positions the company as a reliable partner for clients needing compliant, rapid CRO services for BA/BE studies, clinical development, and biologics.

Full-Service Capabilities Offering end-to-end services across BA/BE, Phase II–IV clinical development, post-marketing support, regulatory consulting, and biologics for biosimilars and novel biologics, enabling cross-selling opportunities to biopharma, biotech, and device clients seeking integrated outsourcing.

Global Reach With over two decades of experience and a global client base in bio-pharma, biotech, medical devices, nutraceuticals, and FMCG, there is potential to expand into additional markets or deepen engagements with multinational sponsors seeking established CRO partnerships.

Scale and Quality Advantage Mid-sized CRO profile with 500–1,000 employees and a qualified, scalable operations model, allowing targeted pitches to mid-cap sponsors looking for reliable capacity, quality, and faster turnaround times at competitive pricing.

Revenue Growth Potential Current revenue range of 10–25 million USD suggests opportunities to upsell expanded BA/BE programs, clinical trials, and biologics services to existing clients while pursuing new deals with similar or larger CROs seeking supplemental capacity.